(Q46813053)

English

The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210.

scientific article published on 13 January 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

ascending cholangitis

0 references

M. Eric Gershwin

14

object named as

M E Gershwin

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

author name string

F Yang

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

Y Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

Q Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

Z Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

Q Miao

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

X Xiao

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

Y Wei

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

Z Bian

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

L Sheng

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

X Chen

10

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

D Qiu

11

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

J Fang

12

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

R Tang

13

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

X Ma

15

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

language of work or name

0 references

publication date

13 January 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

45

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

733-743

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Using GWAS to identify genetic predisposition in hepatic autoimmunity

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Diego and Giorgina Vergani: The two hearts of translational autoimmunity

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Unmet challenges in immune-mediated hepatobiliary diseases.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

AAV-IL-22 modifies liver chemokine activity and ameliorates portal inflammation in murine autoimmune cholangitis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

The immunogenetics of primary biliary cirrhosis: A comprehensive review

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Grading and staging systems for inflammation and fibrosis in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Risk factors in autism: Thinking outside the brain

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Citrullinated Autoantigens: From Diagnostic Markers to Pathogenetic Mechanisms.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.13927

21 January 2018

Identifiers

10.1111/APT.13927

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/28083929

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46813053&oldid=1707278216"